2016 American Transplant Congress » Poster Session C: Viruses and SOT

Date: Monday, June 13, 2016

Time: 6:00pm-7:00pm

Location: Halls C&D

Session Type: Poster Session

Meeting: 2016 American Transplant Congress

6:00pm-7:00pm: Adenovirus Infection in Kidney Transplant Recipients: Report of a Case Series.

C. Simancas-Ruiz, L. Marino-Vazquez, A. Meraz-Muñoz, A. Nuñez-Abreu, R. Rivera-Marfil, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.

6:00pm-7:00pm: An Evaluation of the Safety, Efficacy, and Pharmacoeconomics of Two Valganciclovir Prophylaxis Regimens Following Renal Transplantation.

J. Chen,¹ R. Hoffman,² M. Thomas,² J. Gervasio.²

6:00pm-7:00pm: CMV Monitoring Reduces Risk of Clinical Complications in Kidney Transplant Recipients.

A. Gilbert, M. Cooper, J. Verbesey, R. Ghasemian, P. Abrams, J. Moore, M. Grafals, J. Chahine, S. Punnett, E. Hall, I. Anzak, B. Javaid.

6:00pm-7:00pm: Characteristics of Human Rhinovirus (HRV) Infections in Transplant Recipients.

H. Crossman,¹ M. Barron,¹ M. Levi.¹

6:00pm-7:00pm: Clinical Predictors of Progression and Clearance of Low Level CMV Viremia in Solid Organ Transplant Recipients.

A. Alghamdi, A. Humar, Y. Natori, S. Husain, L. Singer, E. Renner, C. Rotstein, D. Kumar.

6:00pm-7:00pm: Comparative Effectiveness of Cytomegalovirus Prevention Strategies in a Large Retrospective Cohort of Kidney Transplant Recipients.

C. Santos, M. Saeed, D. Brennan, M. Olsen.

6:00pm-7:00pm: Cytomegalovirus Infection After Cardiac Transplantation.

O. Kiamanesh, A. Khosla, C. Imai, E. Johansson, S. Virani, M. Davis, A. Cheung, J. Bashir, B. Munt, A. Ignaszewski, A. Kaan, M. Toma.

6:00pm-7:00pm: Development of a Sequencing-Based Cytomegalovirus UL55 Glycoprotein B (gB) Genotyping Assay.

S. Cowden, K. Grantham, I. Caton, J. Hester, M. Altrich, S. Kleiboeker.

6:00pm-7:00pm: Direct Detection of T and B Memory Lymphocytes Reveals HCMV Exposure That Serum Antibodies Fail to Identify.

S. Sundararaman, F. Terlutter, T. Nowacki, R. Caspell, P. Lehmann.

6:00pm-7:00pm: Donor Transmited Rabies Outbreak Involving Four Transplant Recepients in Kuwait and Saudi Arabia.

H. Elsiesy,^1,2 I. Hussain,³ F. Abaalkhail,^1,2 W. Al-Hamoudi,¹ H. Elbeshbeshy,¹ M. Al Sebayel,¹ D. Broering,¹ A. Elgohary,¹ S. Al Fawaz,⁴ S. Althawadi,⁵ J. Alotaibi,⁴ H. AlHindi,⁵ P. Nair,⁶ T. Al- Otaibi,⁶ N. Nampoory,⁶ L. Orciar,⁷ A. Velasco-Villa,⁷ P. Yager,⁷ T. Smith,⁷ W. Carson,⁷ M. Niezgoda,⁷ A. Wadhwa,⁷ R. Edgar Condori,⁷ Y. Li,⁷ R. Franka,⁷ M. Halim,⁴ R. Willoughby.⁸

6:00pm-7:00pm: Down-Regulated of Circulating miR-29b, miR-185 and NR_073415.2 in Post-Transplanted Patients with Cytomegalovirus Infection May Serve as Novel Biomarkers for Early Diagnosis.

A. Yang, W. Ju, Z. Guo, C. Wu, J. Lin, M. Chen, R. Deng, E. Chen, Y. Gao, X. Zhu, X. He.

6:00pm-7:00pm: Evaluating Posttransplant BKV-Specific T Cell Responses in Patients with Alemtuzumab Induction and Belatacept-Based Regimen.

M. McRae, T. How, A. Kirk, H. Xu.

6:00pm-7:00pm: Evaluation of the Impact of the Implementation of a Specialty Pharmacy Program in the Treatment of Hepatitis C (HCV).

E. Aldag, T. Pedone, R. Pedersen, S. Besur, K. Safdar, A. Sahajpal.

6:00pm-7:00pm: Hepatitis B Reactivation Among Non-Liver Solid Organ Transplant Recipients.

A. Gonzalez, F. Forouton, A. Humar, S. Husain.

6:00pm-7:00pm: Implementation of a Risk Stratified Approach for Prevention of Hepatitis B Reactivation Post Kidney Transplant.

M. Cote,¹ M. Pavlakis,² J. Ethridge,¹ C. Currier,² M. Curry,² E. Khankin,² F. Cardarelli,² K. Richards,^1,2 C. Rogers.^1,2

6:00pm-7:00pm: Influence of Country-Associated Geographical Variables in the Ouctomes of Kidney Transplantation in Patients with HIV-Infection.

M. Cristelli,¹ F. Cofán,² H. Tedesco-Silva,¹ J. Trullas,³ D. Santos,¹ C. Manzardo,⁴ F. Aguero,⁴ A. Moreno,⁴ F. Oppenheimer,² F. Dieckmann,¹ J. Miro,⁴ J. Medina-Pestana.¹

6:00pm-7:00pm: Initial Evaluation of Use of NAT in Assignment of CMV and EBV Infection Status in Children Awaiting Solid Organ Transplant.

C. Burton, Y. Tong, J. Preiksaitis.

6:00pm-7:00pm: Kinetics of Cytomegalovirus Load in Kidney Transplant Recipients Receiving Everolimus or Mycophenolate Sodium and No Pharmacological Prophylaxis.

G. Basso, C. Felipe, A. Ferreira, M. Cristelli, N. Oliveira, T. Sandes-Freitas, J. Mansur, L. Viana, W. Aguiar, E. Campos, M. Gerbasi-DeLima, H. Tedesco-Silva, J. Medina-Pestana.

6:00pm-7:00pm: Neuro-invasive Saint Louis Encephalitis Virus (SLEV) Infection in Solid Organ Transplant Recipients in a Non-Endemic Area.

C. Hartmann, I. Qaqish, T. Grys, H. Vikram, M. Seville, R. Orenstein, S. Kusne, J. Blair, R. Patron.

6:00pm-7:00pm: Outcomes of Solid Organ Transplantation from an HIV Positive Donor to Negative Recipients.

S.-N. Lin,¹ M.-K. Tsai,¹ C.-Y. Luo,² C.-Y. Lee,¹ R.-H. Hu,¹ J.-M. Lee,¹ H.-S. Lai.¹

6:00pm-7:00pm: Outcomes of Transplant Recipients Treated with Cidofovir for Resistant or Refractory Cytomegalovirus Infection.

S. Mehta, M. Alfares, A. Valsamakis, S. Shoham, R. Boger, L. Lees, D. Ostrander, R. Avery.

6:00pm-7:00pm: Parainfluenza-3 Infections Early After Kidney Transplantation.

I. Helanterä,¹ V.-J. Anttila,² M. Lempinen.¹

6:00pm-7:00pm: Parameters of Uremia-Associated Premature Ageing of Peripheral T Cells Do Not Predict Infectious Complications After Renal Transplantation.

B. Dedeoglu, R. Meijers, M. Klepper, D. Hesselink, C. Baan, N. Litjens, M. Betjes.

6:00pm-7:00pm: Polyfunctionality of CD8 T Cell Responses to Cytomegalovirus in Transplant Patients.

L. Higdon,¹ K. Margulies,² J. Maltzman.^1,3

6:00pm-7:00pm: Predictors of Post Transplant Lymphoprolipherative Disorder Among Adult Kidney Transplant Recipients.

M. Mohamed, S. Parajuli, B. Muth, A. Djamali, B. Astor.

6:00pm-7:00pm: Preemptive CMV Prophylaxis in Renal Transplant Recipients Receiving Everolimus Immunosuppression Reduces Cytomegalovirus Infection.

G. Spagnoletti, M. Salerno, V. Bianchi, N. Silvestrini, F. Apponi, J. Romagnoli.

6:00pm-7:00pm: Prophylactic Anti-Virus Therapy, Is It Necessary to Occult Hepatitis B Virus Carriers with HBsAg(-) and HBcAb(+) After Kidney Transplantation?

G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang.

6:00pm-7:00pm: Quantiferon-CMV Test, CMV-Specific ELISPOT and CMV-Dextramer Assays in Assessing the Risk of CMV Infection in Seropositive Kidney Transplant Recipients.

H. Lee,¹ K. Park,² J. Ryu,² J. Yu,³ B. Chung,³ C. Yang,³ E.-J. Oh.¹

6:00pm-7:00pm: Reduced-Dose Cidofovir (CID) and CMV-Hyperimmune Globulin (CMVIg) for Ganciclovir-Resistant Cytomegalovirus: Effective and Kidney Friendly.

S. Patel, S. Kuten, J. Snyder, R. Knight, A. Gaber.

6:00pm-7:00pm: Risk Factors for the Development of CMV Viremia in a Cohort of Morbidly Obese Kidney Transplant Recipients Under Low Dose Valganciclovir Prophylaxis.

J. Thielke,¹ N. Jasiak,¹ N. Hilal,¹ S. Salah,¹ E. Benedetti,² P. West-Thielke.²